Literature DB >> 8544197

Unusual expression of Gaucher's disease: cardiovascular calcifications in three sibs homozygous for the D409H mutation.

A Chabás1, B Cormand, D Grinberg, J M Burguera, S Balcells, J L Merino, I Mate, J A Sobrino, R Gonzàlez-Duarte, L Vilageliu.   

Abstract

Three sisters suffering from an unusual form of Gaucher's disease are described. These patients had cardiovascular abnormalities consisting of calcification of the ascending aorta and of the aortic and mitral valves. Neurological findings included ophthalmoplegia and saccadic eye movements in two patients, and tonic-clonic seizures in the third. The three patients died, two of them after having undergone aortic valve replacement. Tissue was obtained from one of the sibs and fibroblast and liver beta-glucocerebrosidase activity was reduced to 4% and 11% of mean normal values. Genotype analysis indicated that the patient was homozygous for the D409H mutation. It is tempting to relate the phenotype of severe cardiac involvement to the D409H/D409H genotype, although further cases will be needed before this association can be confirmed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8544197      PMCID: PMC1051678          DOI: 10.1136/jmg.32.9.740

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  15 in total

1.  Gaucher's disease with mitral and aortic involvement: echocardiographic findings.

Authors:  M Saraçlar; S Atalay; N Koçak; S Ozkutlu
Journal:  Pediatr Cardiol       Date:  1992-01       Impact factor: 1.655

Review 2.  Gaucher disease: new molecular approaches to diagnosis and treatment.

Authors:  E Beutler
Journal:  Science       Date:  1992-05-08       Impact factor: 47.728

3.  Oculomotor apraxia: the presenting sign of Gaucher disease.

Authors:  V Gross-Tsur; Y Har-Even; I Gutman; N Amir
Journal:  Pediatr Neurol       Date:  1989 Mar-Apr       Impact factor: 3.372

4.  Calcification of the ascending aorta and aortic and mitral valves in Gaucher's disease.

Authors:  A Casta; K Hayden; W J Wolf
Journal:  Am J Cardiol       Date:  1984-12-01       Impact factor: 2.778

5.  Vascular involvement in type 3 neuronopathic Gaucher's disease.

Authors:  E R Wilson; N W Barton; J A Barranger
Journal:  Arch Pathol Lab Med       Date:  1985-01       Impact factor: 5.534

6.  Enzymic differentiation of neurologic and nonneurologic forms of Gaucher's disease.

Authors:  R H Glew; L B Daniels; L S Clark; S W Hoyer
Journal:  J Neuropathol Exp Neurol       Date:  1982-11       Impact factor: 3.685

7.  Isolated horizontal supranuclear gaze palsy as a marker of severe systemic involvement in Gaucher's disease.

Authors:  M C Patterson; M Horowitz; R B Abel; J N Currie; K T Yu; C Kaneski; J J Higgins; R R O'Neill; P Fedio; A Pikus
Journal:  Neurology       Date:  1993-10       Impact factor: 9.910

8.  Unusual cardiac, renal and pulmonary involvement in Gaucher's disease. Intersitial glucocerebroside accumulation, pulmonary hypertension and fatal bone marrow embolization.

Authors:  R L Smith; G M Hutchins; G H Sack; R L Ridolfi
Journal:  Am J Med       Date:  1978-08       Impact factor: 4.965

9.  An activator protein of oligosaccharide sialidase.

Authors:  A Chabás; A Guardiola; J M Burguera
Journal:  Biochem Int       Date:  1987-08

10.  Phenotype/genotype correlations in Gaucher disease type I: clinical and therapeutic implications.

Authors:  A Sibille; C M Eng; S J Kim; G Pastores; G A Grabowski
Journal:  Am J Hum Genet       Date:  1993-06       Impact factor: 11.025

View more
  26 in total

1.  Gaucher's Disease with Cardiac Valve Calcification and Stenosis: A Rare Presentation due to Homozygous p.D409H Mutation in a North Indian Family.

Authors:  Pulkit Rastogi; Sandeep Rao; Jasbir Kaur; Pankaj Malhotra; Subhash Varma; Reena Das
Journal:  Indian J Pediatr       Date:  2016-02-18       Impact factor: 1.967

2.  Gaucher disease plus.

Authors:  E Sidransky; E I Ginns
Journal:  J Med Genet       Date:  1997-10       Impact factor: 6.318

3.  Neuronopathic and non-neuronopathic presentation of Gaucher disease in patients with the third most common mutation (D409H) in Spain.

Authors:  A Chabás; B Cormand; S Balcells; R González-Duarte; C Casanova; J Colomer; L Vilageliu; D Grinberg
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

4.  D409H/D409H genotype in Gaucher-like disease.

Authors:  E Uyama; M Uchino; H Ida; Y Eto; M Owada
Journal:  J Med Genet       Date:  1997-02       Impact factor: 6.318

Review 5.  Metabolic cardiomyopathies.

Authors:  B Guertl; C Noehammer; G Hoefler
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

6.  Recurrence of the D409H mutation in Spanish Gaucher disease patients: description of a new homozygous patient and haplotype analysis.

Authors:  A Chabás; L Gort; M Montfort; F Castelló; M C Domínguez; D Grinberg; L Vilageliu
Journal:  J Med Genet       Date:  1998-09       Impact factor: 6.318

Review 7.  Genetic determinants of cardiac hypertrophy.

Authors:  Ali J Marian
Journal:  Curr Opin Cardiol       Date:  2008-05       Impact factor: 2.161

8.  Clinical and molecular characteristics of Japanese Gaucher disease.

Authors:  Y Eto; H Ida
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

9.  Gaucher's disease type III C: Unusual cause of intracardiac calcification.

Authors:  Sejal Shah; Amit Misri; Meenakshi Bhat; Sunita Maheshwari
Journal:  Ann Pediatr Cardiol       Date:  2008-07

10.  Vitamin D receptor (VDR) polymorphisms in the cardiac variant of Gaucher disease.

Authors:  Allen Greenwood; Gheona Altarescu; Ari Zimran; Deborah Elstein
Journal:  Pediatr Cardiol       Date:  2009-09-26       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.